Crinetics Pharmaceuticals Preferred Securities out of Shareholders Equity (Quarterly) Analysis

Crinetics Pharmaceuticals, Inc. (CRNX)

41.10 -2.64 (-6.04%) USD | NASDAQ | Feb 27, 16:00

41.10 0.00 (0.00%) After-Hours: 20:00

View Preferred Securities out of Shareholders Equity (Quarterly) for CRNX.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Preferred Securities out of Shareholders Equity (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Preferred Securities out of Shareholders Equity (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Preferred Securities out of Shareholders Equity (Quarterly) Benchmarks

Start Trial

Plus Therapeutics, Inc.	--
Madrigal Pharmaceuticals, Inc.	--
GT Biopharma, Inc.	--
Axsome Therapeutics, Inc.	--
Sutro Biopharma, Inc.	--